Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dang gui bu xue tang (DGBXT) is a classic Traditional Chinese Medicine (TCM) formula consisting of Radix Astragali (Huang Qi) and Radix Angelicae Sinensis (Dang Gui) in a 5:1 ratio. In the context of Gansu Provincial Hospital of Traditional Chinese Medicine, it is utilized for treating knee osteoarthritis and degenerative bone and joint diseases. The formula is designed to tonify Qi and generate blood. Pharmacologically, it exhibits anti-inflammatory, analgesic, and chondroprotective properties by inhibiting pro-inflammatory cytokines like IL-1β and TNF-α, and reducing the expression of matrix metalloproteinases (MMPs) that degrade joint cartilage. It also promotes microcirculation and supports bone metabolism.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on dang gui bu xue tang.